Literature DB >> 8524829

The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.

R Pulido1, C Serra-Pagès, M Tang, M Streuli.   

Abstract

The transmembrane protein-tyrosine-phosphatases (PTPases) LAR, PTP delta, and PTP sigma each contain two intracellular PTPase domains and an extracellular region consisting of Ig-like and fibronectin type III-like domains. We describe the cloning and characterization of human PTP sigma (HPTP sigma) and compare the structure, alternative splicing, tissue distribution, and PTPase activity of LAR, HPTP delta, and HPTP sigma, as well their ability to associate with the intracellular coiled-coil LAR-interacting protein LIP.1. Overall, these three PTPases are structurally very similar, sharing 64% amino acid identity. Multiple isoforms of LAR, HPTP delta, and HPTP sigma appear to be generated by tissue-specific alternative splicing of up to four mini-exon segments that encode peptides of 4-16 aa located in both the extracellular and intracellular regions. Alternative usage of these peptides varies depending on the tissue mRNA analyzed. Short isoforms of both HPTP sigma and HPTP delta were also detected that contain only four of the eight fibronectin type III-like domains. Northern blot analysis indicates that LAR and HPTP sigma are broadly distributed whereas HPTP delta expression is largely restricted to brain, as is the short HPTP sigma isoform containing only four fibronectin type III-like domains. LAR, HPTP delta, and HPTP sigma exhibit similar in vitro PTPase activities and all three interact with LIP.1, which has been postulated to recruit LAR to focal adhesions. Thus, these closely related PTPases may perform similar functions in various tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524829      PMCID: PMC40467          DOI: 10.1073/pnas.92.25.11686

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding.

Authors:  J Sap; Y P Jiang; D Friedlander; M Grumet; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

Review 2.  Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

Authors:  T Hunter
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

3.  Genomic organization of the human LAR protein tyrosine phosphatase gene and alternative splicing in the extracellular fibronectin type-III domains.

Authors:  P O'Grady; N X Krueger; M Streuli; H Saito
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

4.  Molecular characterization of the human transmembrane protein-tyrosine phosphatase delta. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase delta isoforms.

Authors:  R Pulido; N X Krueger; C Serra-Pagès; H Saito; M Streuli
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

5.  Developmentally regulated expression of a murine receptor-type protein tyrosine phosphatase in the thymus.

Authors:  M Ogata; M Sawada; A Kosugi; T Hamaoka
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

Review 6.  CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development.

Authors:  I S Trowbridge; M L Thomas
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.

Authors:  J Gyuris; E Golemis; H Chertkov; R Brent
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

8.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.

Authors:  T N Stitt; G Conn; M Gore; C Lai; J Bruno; C Radziejewski; K Mattsson; J Fisher; D R Gies; P F Jones
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

9.  Molecular cloning and tissue-specific RNA processing of a murine receptor-type protein tyrosine phosphatase.

Authors:  J Wagner; D Boerboom; M L Tremblay
Journal:  Eur J Biochem       Date:  1994-12-15

10.  LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats.

Authors:  J S Zhang; F M Longo
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  75 in total

1.  Activated caspase detection in living tissue combined with subsequent retrograde labeling, immunohistochemistry or in situ hybridization in whole-mounted lamprey brains.

Authors:  Jianli Hu; Guixin Zhang; Michael E Selzer
Journal:  J Neurosci Methods       Date:  2013-09-08       Impact factor: 2.390

2.  Differential activities in adhesion and neurite growth of fibronectin type III repeats in the PTP-delta extracellular domain.

Authors:  Manuel R Gonzalez-Brito; John L Bixby
Journal:  Int J Dev Neurosci       Date:  2006-10-10       Impact factor: 2.457

Review 3.  Structural genomics of protein phosphatases.

Authors:  Steven C Almo; Jeffrey B Bonanno; J Michael Sauder; Spencer Emtage; Teresa P Dilorenzo; Vladimir Malashkevich; Steven R Wasserman; S Swaminathan; Subramaniam Eswaramoorthy; Rakhi Agarwal; Desigan Kumaran; Mahendra Madegowda; Sugadev Ragumani; Yury Patskovsky; Johnjeff Alvarado; Udupi A Ramagopal; Joana Faber-Barata; Mark R Chance; Andrej Sali; Andras Fiser; Zhong-yin Zhang; David S Lawrence; Stephen K Burley
Journal:  J Struct Funct Genomics       Date:  2007-12-05

Review 4.  Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization.

Authors:  Hideto Takahashi; Ann Marie Craig
Journal:  Trends Neurosci       Date:  2013-07-05       Impact factor: 13.837

5.  CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes.

Authors:  D H Ng; M D Jabali; A Maiti; P Borodchak; K W Harder; T Brocker; B Malissen; F R Jirik; P Johnson
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  Identification of novel, less toxic PTP-LAR inhibitors using in silico strategies: pharmacophore modeling, SADMET-based virtual screening and docking.

Authors:  Dara Ajay; M Elizabeth Sobhia
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

Review 7.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

8.  Structural and Biochemical Basis for the Inhibitory Effect of Liprin-α3 on Mouse Diaphanous 1 (mDia1) Function.

Authors:  Julian Brenig; Susanne de Boor; Philipp Knyphausen; Nora Kuhlmann; Sarah Wroblowski; Linda Baldus; Lukas Scislowski; Oliver Artz; Philip Trauschies; Ulrich Baumann; Ines Neundorf; Michael Lammers
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

9.  Leukocyte antigen-related protein tyrosine phosphatase negatively regulates hydrogen peroxide-induced vascular smooth muscle cell apoptosis.

Authors:  Juxiang Li; Xi-Lin Niu; Nageswara R Madamanchi
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

10.  Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.

Authors:  Jing Jin; Yong Cheng; Yongqing Zhang; William Wood; Qi Peng; Emmette Hutchison; Mark P Mattson; Kevin G Becker; Wenzhen Duan
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.